Radiology Oncology Surgical Robots Market Worth $7.3 Billion by 2022
PUNE, India, January 19, 2016 /PRNewswire/ --
Worldwide Radiology Oncology surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and use radiology for cancer surgery. New systems pinpoint the delivery of radiation precisely, eliminating the radiological overdosing that has been such a problem previously, limiting the quantity of radiation that can be delivered.
Complete report on radiology oncology surgical robots market spread across 557 pages, analyzing 3 major companies and providing 82 tables and figures is now available at http://www.rnrmarketresearch.com/radiology-oncology-surgical-robots-market-shares-strategies-and-forecasts-worldwide-2016-to-2022-market-report.html.
Radiology Oncology surgical robot device markets at $4 billion in 2015 are anticipated to reach $7.3 billion by 2022 as next generation devices, systems, and instruments are introduced to manage cancer surgery through radiation excision that eliminates open cutting in the body. Patients tolerate the surgery well, walking out of the hospital after the procedure no longer bothered by healing or infection from an incision.
Companies Profiled include Varian, Elekta and Accuray, Best Theratronics, Ltd, Brainlab AG, Mitsubishi Heavy Industries and ViewRay. The radiation oncology market is growing globally due to a number of factors centered around the aging of the population and the benefits accrued from new technology. The number of new cancer cases diagnosed annually is projected to increase from 14.9 million in 2015 to 20 million by 2025. The increase in new cases is due to a steadily aging population. Both developed and developing countries have aging populations.
Technology advances improve the precision and applicability of radiotherapy and radiosurgery. Expanding uses of radiotherapy and radiosurgery equipment occur because the units are able to treat a broader range of cases. Advances in hardware and software are creating a market for replacing an aging installed base. New designs are able to deliver higher standards of care. Order a copy of Radiology Oncology Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2016 to 2022 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=454116.
Technology advances lead to improvements in patient care. The availability of advanced, automated and efficient clinical tools in radiation therapy has brought more precise forms of radiotherapy treatment (IMRT, IGRT, VMAT, SRS, SBRT, brachytherapy and proton therapy). Technology includes the EDGE™ and Truebeam™, and the Accuray TomoTherapy H Series and CyberKnife M6 platforms that enable treatments that reduce treatment times and increase patient throughput .
9,000 additional treatment machines will be required by 2020 in developing countries. China, India and Brazil are estimated to require over 3,800, 1,200 and 400 additional machines. Demand in emerging markets, coupled with ever increasing incidences of cancer, represent additional drivers for continued growth.
Radiology oncology surgical robot market driving forces relate to an opportunity to achieve change in medical practice regarding the treatment of cancer. Change would lead to utilization of stereotactic body radiosurgery more regularly as an alternative to surgery or other treatments. Radiosurgery is poised to revolutionize the treatment of cancer by eradicating tumors while not harming surrounding healthy tissue.
The Varian, Elekta, and Accuray radiology oncology surgical devices offer robust clinical treatment capabilities. Flexibility of the Accuray InCise™ Multileaf Collimator and robotic delivery permit treatment of tumors previously thought untreatable. With radiosurgery and SBRT cancer can be treated efficiently and effectively. The device offers accuracy.
Existing open brain and abdominal cancer surgery can be replaced in large part during the forecast period by robotic radiological oncology surgery. Radiologic robotic surgical approaches complement existing open surgery techniques, but will replace them as more physicians and surgeons become skilled in manipulating the x-ray devices. Soon, all oncology surgery will be considered in the context of what part of the oncology procedure will be undertaken with at least some aspects of robotic radiologic surgery replacing or complementing open cancer surgery.
Another related report is Abdominal Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021; the 2015 study has 416 pages, 176 tables and figures. Abdominal surgical robot device markets at $2.2 billion in 2014 are anticipated to reach $10.5 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds. Access the complete report at http://www.rnrmarketresearch.com/abdominal-surgical-robots-market-shares-strategies-and-forecasts-worldwide-2015-to-2021-market-report.html.
Explore more reports on surgical equipments market at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices/surgical-equipment .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
[email protected]
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
Twitter: https://twitter.com/RnRMR
Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345
Share this article